The present study was undertaken to define the effects of left ventricular hypertrophy on postischemic recovery of myocardial performance and high energy phosphate metabolism.
Standardization ofNMR Data
Parallel studies were carried out on preparations of myocardium for the three animal groups. Hearts from the various animal models were freeze clamped by use of a stimulator-regulated-triggered freeze clamp, which decreases the temperature of the heart from 370 C to -80°C in 5 msec26 at a predetermined phase of the cardiac cycle. Heart tissue extracts were prepared as described previously. (pH 3.0) . Detection was at 210 nm. PCr and creatine (Cr) were eluted at 1.5 ml/min with 0.3% KH2PO4 and 0.1% TBA (pH 3.0). PCr, Cr, and nucleotides were quantified by integration of defined peaks of unknowns in relation to integration of defined peaks of known standards. Values were expressed as micromoles per gram dry weight and converted to micromoles per gram wet weight and then to molar concentrations. 29 Only control conditions of the various animal models were standardized by HPLC analysis of freeze-clamped tissue; all other values for the same heart were based on control conditions. This methodology was possible because hearts did not normally move from the NMR detection area, as shown by the consistency in the ratio of heart spectra to spectra of a standard sealed inside the NMR tube.
Calculation of Extracellular Space
In parallel experiments extracellular space was calculated as follows: Co[EDTA] was synthesized by the method of Dwyer et a130 and added to the perfusate at a concentration of 0.6 mM. Cobalt in this form is impermeable to the cell. At the end of the experiment the hearts were removed from the perfusion apparatus, weighed, and minced. A dry weight of the heart was obtained after 72 hours at 1100 C. The difference between wet and dry heart weight yields the volume of heart water based on the assumption 1 g=1 ml H20. Total myocardial cobalt content was measured by atomic absorption spectrophotometry on a Model 2380 spectrophotometer (Perkin-Elmer, Norwalk, Connecticut) after acid extraction. Samples were compared with standards from the Department of Commerce, National Bureau of Standards, and analyzed over the linear range. Statistical Analysis Values are reported as mean+SEM unless otherwise indicated. For detection of significant differences between the groups, Scheff6's test for multiple contrasts by analysis of variance was applied. Student's t test was used for detection of significant differences within a group. The null hypothesis was rejected at the 95% level, with p<0.05 considered significant.
Results

Severity of Left Ventricular Hypertrophy
Left ventricular hypertrophy is characterized in Table 1 . Compared with controls, dry heart weight increased 65% in constricted rats and 59% in thyroxine-treated rats. Both hearts were significantly larger than normal rat hearts (p<0.01). The dry heart weight/body weight ratios were also significantly higher for the constricted and thyroxinetreated rats as compared with normal rats (p<0.01). Based on the two-dimensional echocardiographs, the end-diastolic wall thickness was 3.50±0.12 mm in controls, 4.92±0.09 mm in aortic-constricted hearts, and 4.31 ± 0.05 mm in thyroxine-treated hearts ( Table  2 ). The left ventricular myocardial volume was 1,295+79 mm' in controls, 1,999±58 mm3 in hearts from aortic-constricted rats, and 1,824±99 mm3 in hearts from thyroxine-treated rats (Table 2) . Hemodynamics Within 3 minutes of global ischemia, left ventricular developed pressure decreased to zero in all three groups (Figure 1 ). During the early reperfusion phase mechanical performance and heart rhythm were unstable in aortic-constricted rat hearts. After 30 minutes of reperfusion left ventricular developed pressure recovered 43±4% of the initial baseline value in constricted, 86±4% in normal, and 100±4% in thyroxine-treated rat hearts. Percent recovery of developed pressure was significantly lower in constricted hearts (p<0.01) and normal hearts (p<0.01), but there was no significant difference after reperfusion in thyroxine-treated hearts. The same was true for the absolute values of developed pressure (Table 1) . Heart rate before ischemia was 222+12 for normal hearts, 233+11 for hearts from aortic-constricted animals, and 241+±13 for thyroxinetreated hearts. After 30 minutes of reperfusion heart rate was 205 +9 for normal, 206+10 for constricted, and 212±11 for thyroxine-treated hearts.
There was no significant difference in the coronary reserve of hearts from thyroxine-treated animals as compared with hearts from aortic-constricted animals, either before or after ischemia. Coronary resistance was significantly higher in hearts from aorticconstricted animals (p<0.001) as compared with hearts from normal or thyroxine-treated rats (Table  1) . Only in hearts from aortic-constricted rats was the coronary resistance significantly lower after ischemia (p<0.01) ( Table 1) ; this decrease was due to the rise in end-diastolic pressure after ischemia in these animals. Hearts from both normal and aorticconstricted rats showed a significant rise in enddiastolic pressure after 30 minutes of ischemia (p<0.01) ( Table 1 ). No significant difference was noted in end-diastolic pressure after ischemia in hearts from thyroxine-treated animals. Coronary flow and oxygen consumption were significantly lower in hearts from aortic-constricted animals as compared with hearts from either normal or thyroxine-treated animals (p<0.001). There 
3`P-NMR Analysis
Representative 31P-NMR spectra of each group during control conditions and with ischemia and reperfusion are shown in Figure 2 . The percent changes in the normalized 31P-NMR spectra are shown in Table 3 for the three groups for Pi, PCr, /3-ATP, and phosphorylation potential. Left ventricular developed pressure is also shown for comparison with the NMR data.
The 31P-NMR data after normalization and standardization are shown in Table 4 for the three groups. A time course for the change in the normalized and standardized 31P-NMR data for each group is shown in Figure 3A for Pi, Figure 3B for PCr, Figure 3C for ,B-ATP, and Figure 3D for intracellular pH. Figure 4 gives the phosphorylation potential before and after ischemia for the three groups. The alterations in PCr and ,-ATP during ischemia were similar among the three groups and were characterized by an abrupt decline in PCr and a gradual decrease in f3-ATP. Thyroxine-treated hearts showed a significantly higher Pi and a significantly lower intracellular pH compared with normal and constricted hearts after 30 minutes of global ischemia. After ischemia the y-P/13-P (as defined in Figure 2 ; data not shown) was also significantly lower (p<0.05) in thyroxine-treated hearts (1.1±0.2 vs. 1.7±0.2 in hearts from aortic-constricted rats and 1.5±0.2 in normal hearts), indicating that a greater amount of ADP was bound in thyroxine-treated hearts. There was no coronary flow during the ischemia period; thus, the difference in free ADP could not be accounted for by efflux. This finding was confirmed by absence of significant difference among the three groups of hearts in total ADP after ischemia (3.6 ±0.4 mM for normal hearts, 3.8±0.3 mM for hearts from aortic-constricted rats, and 3.5±0.3 mM for hearts from thyroxine-treated rats).
Changes in the phosphate peaks during reperfusion were significantly different among the three groups of animals ( Figure 3 , and Tables 3 and 4). At 10 minutes of reperfusion Pi declined substantially in normal and thyroxine-treated hearts but remained substantially elevated for the entire 30 minutes of reperfusion in hearts from aortic-constricted animals. Thus, at the end of the 30-minute reperfusion period Pi was significantly higher in constricted hearts than in hearts from normal animals or thyroxine-treated animals (p<0.01). PCr recovered in excess after 10 minutes of reperfusion in normal hearts and returned to near control levels after 30 minutes of reperfusion in normal and thyroxine-treated hearts. In contrast, recovery of PCr after 30 minutes of reperfusion in hearts from aortic-constricted animals remained severely depressed (Figure 3b) and was significantly lower than hearts from normal or thyroxine-treated animals (Table 4 ) (p<0.01). Recovery of ,B-ATP after 30 minutes of reperfusion was severely depressed in all three groups (Figure 3c ), but significantly lower in hearts from aortic-constricted rats (Table 4 ) (p<0.05).
In hearts from aortic-constricted rats, the percent decrease in left ventricular developed pressure at 30 minutes of postischemic reperfusion was greater than the percent decrease in the phosphorylation potential (Table 3 ). The loss of purine nucleosides in the coronary effluent at 5 minutes of reperfusion was 3.1+0.1 mM in hearts from aortic-constricted animals, 2.2±0.3 mM in hearts from normal animals, and 0.3±0.05 mM in hearts from thyroxine-treated animals. However, at 10 minutes of reperfusion no additional purine nucleosides were detected in the effluent of hearts from normal animals, whereas hearts from constricted and thyroxine-treated animals continued to lose nucleosides (1.6±0.4 and 0.7±0.06, respectively). Therefore, the total loss of purine nucleosides at 5 and 10 minutes of reperfusion was significantly greater in constricted compared with normal hearts (p<0.001) and significantly less in thyroxine-treated compared with normal hearts (p<0.001). Hypertrophied hearts lost purine nucleosides over a longer period than did normal hearts. Discussion After ischemia and postischemic reperfusion normal hearts and hearts with thyroxine-induced hypertrophy recovered developed pressure to approximately 86% and 100% and phosphorylation potential to 91% and 98%, respectively. Recovery of developed pressure and phosphorylation potential can be used as indices of recovery. 16 On the other hand, hypertrophied hearts due to chronic pressure overload recovered developed pressure to approximately 43% and phosphorylation potential to about 82%. The phosphorylation potential takes into consideration all of the energy metabolites as well as intracellular pH, and is expressed as the thermodynamic affinity (KATP) for ATP hydrolysis. The magnitude of the affinity depends on the extent of ATP hydrolysis rather than the Kq-to-mass action ratio, that is,
Under constant temperature and atmospheric pressure, the affinity for ATP hydrolysis is propor- Analysis of the data obtained from the present study indicates that postischemic recovery, which was greatest in hearts from thyroxine-treated animals, did not depend on the level of any of the individual energy metabolites during ischemia. The hearts from thyroxine-treated animals had the lowest intracellular pH, the highest Pi, and the earliest decrease in PCr and ATP, but had the least loss in breakdown products of ATP during reperfusion. A high Pi and a low y-P//p-P (see Figure 2 ) during ischemia may indicate a greater amount of bound ADP, allowing for the more rapid ATP recovery during reperfusion in the thyroxine-treated hearts. Recovery did not relate to work, expressed as developed pressure and oxygen consumption before ischemia, since hearts from thyroxine-treated animals had the highest developed pressure and the highest oxygen consumption before ischemia. Recovery was not related to hypertrophy since there was no significant difference in heart size between the hearts from thyroxinetreated animals and animals subject to aortic constriction. Recovery was not related to end-diastolic pressure before ischemia since there was no significant difference in this parameter among the three groups. On the other hand, recovery was directly related to coronary flow before and after ischemia and inversely related to coronary resistance. Induc- Coronary flow during postischemic reperfusion was not significantly different from preischemic control levels for all three groups of animals. Nevertheless, oxygen consumption was depressed in hearts from all three groups. In normal rat hearts, postischemic-developed pressure was lower than before ischemia; thus, the depressed oxygen consumption may have been due to supply and demand. Oxygen consumption for hearts from rats subject to aortic constriction was depressed but not signifi. cantly. The significant difference in oxygen cpnsumption before and after ischemia inL'hCarts from thyroxine-treated rats is mojresliftWiilt to explain. In thyroxine-treated rats there was a significant decrease in oxygen consumption without a significant decrease in developed pressure during postischemic recovery. The latter condition may have been due to more efficient energy utilization and/or economization of energy by salvaging of bound nucleotides. Also, the heart rate decreased approximately 12%, accounting for some of the decrease in oxygen consumption postischemically.
Hearts from rats subject to aortic constriction have lower oxygen consumption and a shift toward isomyosin V3 (i.e., the myosin with slow ATPase activity conferring thermodynamic efficiency on the heart).12"13 On the other hand, the hearts from thyroxine-induced hypertrophy have been shown to have a shift in isomyosin V1 (i.e., the myosin with fast ATPase activity),'4 thus decreasing the thermodynamic efficiency of the heart. Nevertheless, the hearts from thyroxine-treated animals recovered better than those from aortic-constricted hearts.
In summary, hypertrophied myocardium due to pressure overload has a lesser ability to recover from ischemia than does myocardium hypertrophied by thyroxine. Differences in coronary vasculature and flow may explain much of these results. A greater metabolic reserve in thyroxine-treated animals may also contribute to their greater tolerance of ischemia.
